Predictive Oncology Q1 EPS $(1.04) Compared to $(0.86) YoY, Sales $419.6K Up From $239.9K YoY
Portfolio Pulse from Benzinga Newsdesk
Predictive Oncology reported a Q1 EPS of $(1.04), a decline from $(0.86) year-over-year. However, sales increased to $419.6K from $239.9K YoY.
May 15, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Predictive Oncology's Q1 EPS declined to $(1.04) from $(0.86) YoY, but sales increased to $419.6K from $239.9K YoY. This mixed performance may lead to short-term volatility in the stock price.
The decline in EPS indicates a worsening bottom line, which is negative. However, the increase in sales is a positive sign of growth. These mixed signals are likely to cause short-term volatility as investors digest the news.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100